NCT06122194View on ClinicalTrials.gov

A Study to Learn PF-07817883 Blood Levels After Administration of Tablets of Study Drug to Healthy Adult Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

November 23, 2023

Primary Completion Date

January 12, 2024

Study Completion Date

January 12, 2024

Conditions
Healthy
Interventions
DRUG

Drug: PF-07817883

PF-07817883 tablet

Trial Locations (1)

B-1070

Pfizer Clinical Research Unit - Brussels, Brussels

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT06122194 - A Study to Learn PF-07817883 Blood Levels After Administration of Tablets of Study Drug to Healthy Adult Volunteers | Biotech Hunter | Biotech Hunter